← FDA Drug Approvals (Drugs@FDA)

ERYTHROCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 1986-10-31

Drug application

FDA Application #

ANDA062638

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYTHROCIN

Generic name

ERYTHROMYCIN LACTOBIONATE

Active ingredients

ERYTHROMYCIN LACTOBIONATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

HOSPIRA

Manufacturer

Hospira, Inc.

First approval

1986-10-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown